Patents by Inventor Stuart McRae Allan

Stuart McRae Allan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ADAMTS13 VARIANT
    Publication number: 20240124865
    Abstract: The disclosure provides improved ADAMTS13 variants with amino acid substitutions in the linker 3 region. The disclosure also provides methods for producing and using the variants.
    Type: Application
    Filed: February 17, 2022
    Publication date: April 18, 2024
    Inventors: Stuart McRae Allan, Kieron South
  • Cyclic diarylboron derivatives as NLRP3 inflammasome inhibitors
    Patent number: 10570157
    Abstract: Inhibitor compounds are disclosed. The compounds are effective in the treatment of diseases or conditions in which interleukin 1 ? activity is implicated. Methods of synthesis of the compounds, as well as pharmaceutical compositions comprising the compounds are also disclosed.
    Type: Grant
    Filed: July 28, 2016
    Date of Patent: February 25, 2020
    Assignee: THE UNIVERSITY OF MANCHESTER
    Inventors: David Brough, Stuart McRae Allan, Sally Freeman, Alex George Baldwin
  • CYCLIC DIARYLBORON DERIVATIVES AS NLRP3 INFLAMMASOME INHIBITORS
    Publication number: 20180215772
    Abstract: Inhibitor compounds are disclosed. The compounds are effective in the treatment of diseases or conditions in which interleukin 1 ? activity is implicated. Methods of synthesis of the compounds, as well as pharmaceutical compositions comprising the compounds are also disclosed.
    Type: Application
    Filed: July 28, 2016
    Publication date: August 2, 2018
    Inventors: David Brough, Stuart McRae Allan, Sally Freeman, Alex George Baldwin